The impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on substance use in the United States

JA Ross, PK Malone, S Levy - Clinical Infectious Diseases, 2022 - academic.oup.com
The SARS-CoV-2 pandemic has been associated with dramatic increases in substance use,
as marked by increased alcohol, nicotine, and cannabis sales. Lethal opioid overdoses also …

[HTML][HTML] Severe breakthrough COVID‐19 infections in vaccinated patients with schizophrenia in Israel

DT Bitan, N Givon‐Lavi, K Kridin, E Kaliner… - World …, 2022 - ncbi.nlm.nih.gov
Patients with schizophrenia show a substantial reduction in risk of COVID-19 severe illness
and related mortality when vaccinated, as compared to non-vaccinated samples1. However …

Risk factors for COVID-19 among persons with substance use disorder (PWSUD) with hospital visits–United States, April 2020–December 2020

AR Board, S Kim, J Park, L Schieber, GF Miller… - Drug and Alcohol …, 2022 - Elsevier
Introduction Sociodemographic factors and chronic conditions associated with coronavirus
disease 2019 (COVID-19) among persons with substance use disorder (PWSUD) are not …

Association of recent SARS-CoV-2 infection with new-onset alcohol use disorder, January 2020 through January 2022

VR Olaker, EK Kendall, CX Wang, TV Parran… - JAMA Network …, 2023 - jamanetwork.com
Importance The COVID-19 pandemic affects many diseases, including alcohol use disorders
(AUDs). As the pandemic evolves, understanding the association of a new diagnosis of AUD …

COVID‐19 vaccine effectiveness by HIV status and history of injection drug use: a test‐negative analysis

JH Puyat, J Wilton, A Fowokan… - Journal of the …, 2023 - Wiley Online Library
Introduction People living with HIV (PLWH) and/or who inject drugs may experience lower
vaccine effectiveness (VE) against SARS‐CoV‐2 infection. Methods A validated algorithm …

COVID-19 vaccination and alcohol consumption: justification of risks

PA Solopov - Pathogens, 2023 - mdpi.com
Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic, pharmaceutical companies and research institutions have been actively working …

Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes

L Wang, R Xu, DC Kaelber, NA Berger - JAMA Network Open, 2024 - jamanetwork.com
Importance Thirteen human malignant neoplasms have been identified as obesity-
associated cancers (OACs), ie, the presence of excess body fat is associated with increased …

Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes: Target Trial Emulation Using Real-World Data

W Wang, ND Volkow, NA Berger, PB Davis… - Annals of Internal …, 2024 - acpjournals.org
Background: Reports of reduced desire to smoke in patients treated with semaglutide, a
glucagon-like peptide receptor agonist (GLP-1RA) medication for type 2 diabetes mellitus …

[HTML][HTML] COVID-19 infections post-vaccination by HIV status in the United States

SB Coburn, E Humes, R Lang, C Stewart, BC Hogan… - medRxiv, 2021 - ncbi.nlm.nih.gov
COVID-19 infections post-vaccination by HIV status in the United States - PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

[HTML][HTML] Cognitive impairment after recovery from COVID-19: Frequency, profile, and relationships with clinical and laboratory indices

S Galderisi, A Perrottelli, L Giuliani, MA Pisaturo… - European …, 2024 - Elsevier
Cognitive impairment (CI) is regarded as a remarkable burden in COVID-19 survivors. Its
prevalence and profile, and relationships with the disease clinical and laboratory indices …